{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T05:17:05Z","timestamp":1741065425935,"version":"3.38.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T00:00:00Z","timestamp":1740873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T00:00:00Z","timestamp":1740873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81670179"],"award-info":[{"award-number":["81670179"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Major Subject of Science and Technology of Anhui Province","award":["201903a07020030"],"award-info":[{"award-number":["201903a07020030"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-02670-5","type":"journal-article","created":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T17:10:01Z","timestamp":1740935401000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of herpes zoster vaccine on patients after hematopoietic stem cell transplantation: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"22","author":[{"given":"Xunyi","family":"Jiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinli","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangyang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhimin","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,2]]},"reference":[{"issue":"8","key":"2670_CR1","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/j.1525-1497.2005.0150.x","volume":"20","author":"RP Insinga","year":"2005","unstructured":"Insinga RP, Itzler RF, Pellissier JM, Saddier P, Nikas AA. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med. 2005;20(8):748\u201353. https:\/\/doi.org\/10.1111\/j.1525-1497.2005.0150.x.","journal-title":"J Gen Intern Med"},{"issue":"4","key":"2670_CR2","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1182\/blood.V74.4.1424.1424","volume":"74","author":"LM Schuchter","year":"1989","unstructured":"Schuchter LM, Wingard JR, Piantadosi S, Burns WH, Santos GW, Saral R. Herpes zoster infection after autologous bone marrow transplantation. Blood. 1989;74(4):1424\u20137.","journal-title":"Blood"},{"issue":"7","key":"2670_CR3","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.bbmt.2010.10.025","volume":"17","author":"SH Su","year":"2011","unstructured":"Su SH, Martel-Laferriere V, Labbe AC, Snydman DR, Kent D, Laverdiere M, et al. High incidence of herpes zoster in nonmyeloablative hematopoietic stem cell transplantation. Biol Blood Marrow Transpl. 2011;17(7):1012\u20137. https:\/\/doi.org\/10.1016\/j.bbmt.2010.10.025.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"1","key":"2670_CR4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/s1083-8791","volume":"6","author":"Y Koc","year":"2000","unstructured":"Koc Y, Miller KB, Schenkein DP, Griffith J, Akhtar M, Desjardin J, et al. Varicella Zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome. Biol Blood Marrow Transpl. 2000;6(1):44\u20139. https:\/\/doi.org\/10.1016\/s1083-8791.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"1","key":"2670_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/jdv.13995","volume":"31","author":"RN Werner","year":"2017","unstructured":"Werner RN, Nikkels AF, Marinovic B, Schafer M, Czarnecka-Operacz M, Agius AM, et al. European consensus-based (s2k) guideline on the management of herpes zoster - guided by the European dermatology forum (edf) in cooperation with the European academy of dermatology and venereology (eadv), part 1: diagnosis. J Eur Acad Dermatol Venereol. 2017;31(1):9\u201319. https:\/\/doi.org\/10.1111\/jdv.13995.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"2670_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/jdv.13957","volume":"31","author":"RN Werner","year":"2017","unstructured":"Werner RN, Nikkels AF, Marinovic B, Schafer M, Czarnecka-Operacz M, Agius AM, et al. European consensus-based (s2k) guideline on the management of herpes zoster - guided by the European dermatology forum (edf) in cooperation with the European academy of dermatology and venereology (eadv), part 2: treatment. J Eur Acad Dermatol Venereol. 2017;31(1):20\u20139. https:\/\/doi.org\/10.1111\/jdv.13957.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"2670_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/j.pain.0000000000000307","volume":"157","author":"HJ Forbes","year":"2016","unstructured":"Forbes HJ, Thomas SL, Smeeth L, Clayton T, Farmer R, Bhaskaran K, et al. A systematic review and meta-analysis of risk factors for postherpetic neuralgia. Pain. 2016;157(1):30\u201354. https:\/\/doi.org\/10.1097\/j.pain.0000000000000307.","journal-title":"Pain"},{"issue":"Suppl 1","key":"2670_CR8","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1086\/342963","volume":"186","author":"JJ Gnann","year":"2002","unstructured":"Gnann JJ. Varicella-Zoster virus: atypical presentations and unusual complications. J Infect Dis. 2002;186(Suppl 1):S91\u20138. https:\/\/doi.org\/10.1086\/342963.","journal-title":"J Infect Dis"},{"issue":"22","key":"2670_CR9","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1056\/NEJMoa051016","volume":"352","author":"MN Oxman","year":"2005","unstructured":"Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352(22):2271\u201384. https:\/\/doi.org\/10.1056\/NEJMoa051016.","journal-title":"N Engl J Med"},{"issue":"12","key":"2670_CR10","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.vaccine.2018.02.029","volume":"36","author":"M Kovac","year":"2018","unstructured":"Kovac M, Lal H, Cunningham AL, Levin MJ, Johnson RW, Campora L, et al. Complications of herpes zoster in immunocompetent older adults: incidence in vaccine and placebo groups in two large phase 3 trials. Vaccine. 2018;36(12):1537\u201341. https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.029.","journal-title":"Vaccine"},{"issue":"9","key":"2670_CR11","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/S1473-3099","volume":"19","author":"AF Dagnew","year":"2019","unstructured":"Dagnew AF, Ilhan O, Lee WS, Woszczyk D, Kwak JY, Bowcock S, et al. Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis. Lancet Infect Dis. 2019;19(9):988\u20131000. https:\/\/doi.org\/10.1016\/S1473-3099.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"2670_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/cid\/ciz177","volume":"70","author":"P Vink","year":"2020","unstructured":"Vink P, Ramon TJ, Sanchez FA, Kim SJ, Kim SI, Zaltzman J, et al. Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in chronically immunosuppressed adults following renal transplant: a phase 3, randomized clinical trial. Clin Infect Dis. 2020;70(2):181\u201390. https:\/\/doi.org\/10.1093\/cid\/ciz177.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2670_CR13","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1111\/ajt.16534","volume":"21","author":"C Hirzel","year":"2021","unstructured":"Hirzel C, L\u2019Huillier AG, Ferreira VH, Marinelli T, Ku T, Ierullo M, et al. Safety and immunogenicity of adjuvanted recombinant subunit herpes zoster vaccine in lung transplant recipients. Am J Transpl. 2021;21(6):2246\u201353. https:\/\/doi.org\/10.1111\/ajt.16534.","journal-title":"Am J Transpl"},{"issue":"12","key":"2670_CR14","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.healun.2020.09.001","volume":"39","author":"MH Barghash","year":"2020","unstructured":"Barghash MH, Taimur S, Rana M, Behar J, Mancini DM. Recombinant herpes zoster vaccine after heart transplantation: a single-center experience. J Heart Lung Transpl. 2020;39(12):1501\u20133. https:\/\/doi.org\/10.1016\/j.healun.2020.09.001.","journal-title":"J Heart Lung Transpl"},{"issue":"11","key":"2670_CR15","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","volume":"375","author":"AL Cunningham","year":"2016","unstructured":"Cunningham AL, Lal H, Kovac M, Chlibek R, Hwang SJ, Diez-Domingo J, et al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N Engl J Med. 2016;375(11):1019\u201332. https:\/\/doi.org\/10.1056\/NEJMoa1603800.","journal-title":"N Engl J Med"},{"issue":"22","key":"2670_CR16","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","volume":"372","author":"H Lal","year":"2015","unstructured":"Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang SJ, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. 2015;372(22):2087\u201396. https:\/\/doi.org\/10.1056\/NEJMoa1501184.","journal-title":"N Engl J Med"},{"issue":"15","key":"2670_CR17","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (moose) group. JAMA. 2000;283(15):2008\u201312. https:\/\/doi.org\/10.1001\/jama.283.15.2008.","journal-title":"JAMA"},{"issue":"4","key":"2670_CR18","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the prisma statement. Ann Intern Med. 2009;151(4):264\u20139. https:\/\/doi.org\/10.7326\/0003-4819-151-4-200908180-00135.","journal-title":"Ann Intern Med"},{"issue":"2","key":"2670_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1001\/jama.2019.9053","volume":"322","author":"A Bastidas","year":"2019","unstructured":"Bastidas A, de la Serna J, El IM, Oostvogels L, Quittet P, Lopez-Jimenez J, et al. Effect of recombinant zoster vaccine on incidence of herpes zoster after autologous stem cell transplantation: a randomized clinical trial. JAMA. 2019;322(2):123\u201333. https:\/\/doi.org\/10.1001\/jama.2019.9053.","journal-title":"JAMA"},{"issue":"10135","key":"2670_CR20","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1016\/S0140-6736","volume":"391","author":"DJ Winston","year":"2018","unstructured":"Winston DJ, Mullane KM, Cornely OA, Boeckh MJ, Brown JW, Pergam SA, et al. Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2018;391(10135):2116\u201327. https:\/\/doi.org\/10.1016\/S0140-6736.","journal-title":"Lancet"},{"issue":"4","key":"2670_CR21","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.bbmt.2015.12.025","volume":"22","author":"T Aoki","year":"2016","unstructured":"Aoki T, Koh K, Kawano Y, Mori M, Arakawa Y, Kato M, et al. Safety of live attenuated high-titer varicella-zoster virus vaccine in pediatric allogeneic hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transpl. 2016;22(4):771\u20135. https:\/\/doi.org\/10.1016\/j.bbmt.2015.12.025.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"19","key":"2670_CR22","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1182\/blood-2014-04-573048","volume":"124","author":"EA Stadtmauer","year":"2014","unstructured":"Stadtmauer EA, Sullivan KM, Marty FM, Dadwal SS, Papanicolaou GA, Shea TC, et al. A phase 1\/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients. Blood. 2014;124(19):2921\u20139. https:\/\/doi.org\/10.1182\/blood-2014-04-573048.","journal-title":"Blood"},{"issue":"1","key":"2670_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1056\/NEJMoa013441","volume":"347","author":"A Hata","year":"2002","unstructured":"Hata A, Asanuma H, Rinki M, Sharp M, Wong RM, Blume K, et al. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N Engl J Med. 2002;347(1):26\u201334. https:\/\/doi.org\/10.1056\/NEJMoa013441.","journal-title":"N Engl J Med"},{"key":"2670_CR24","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"J Sterne","year":"2019","unstructured":"Sterne J, Savovic J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. Rob 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898.","journal-title":"BMJ"},{"issue":"9","key":"2670_CR25","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the newcastle-ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135. https:\/\/doi.org\/10.1007\/s10654-010-9491-z.","journal-title":"Eur J Epidemiol"},{"issue":"7414","key":"2670_CR26","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360. https:\/\/doi.org\/10.1136\/bmj.327.7414.557.","journal-title":"BMJ"},{"issue":"1","key":"2670_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12879-019-3719-7","volume":"19","author":"S Ohfuji","year":"2019","unstructured":"Ohfuji S, Ito K, Inoue M, Ishibashi M, Kumashiro H, Hirota Y, et al. Safety of live attenuated varicella-zoster vaccine in patients with underlying illnesses compared with healthy adults: a prospective cohort study. Bmc Infect Dis. 2019;19(1):95. https:\/\/doi.org\/10.1186\/s12879-019-3719-7.","journal-title":"Bmc Infect Dis"},{"issue":"11","key":"2670_CR28","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.7326\/M20-6928","volume":"174","author":"JR Curtis","year":"2021","unstructured":"Curtis JR, Cofield SS, Bridges SJ, Bassler J, Deodhar A, Ford TL, et al. The safety and immunologic effectiveness of the live varicella-zoster vaccine in patients receiving tumor necrosis factor inhibitor therapy: a randomized controlled trial. Ann Intern Med. 2021;174(11):1510\u20138. https:\/\/doi.org\/10.7326\/M20-6928.","journal-title":"Ann Intern Med"},{"issue":"6","key":"2670_CR29","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1093\/cid\/ciab125","volume":"73","author":"HS Izurieta","year":"2021","unstructured":"Izurieta HS, Wu X, Forshee R, Lu Y, Sung HM, Agger PE, et al. Recombinant zoster vaccine (shingrix): real-world effectiveness in the first 2 years post-licensure. Clin Infect Dis. 2021;73(6):941\u20138. https:\/\/doi.org\/10.1093\/cid\/ciab125.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2670_CR30","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1182\/bloodadvances.2020003749","volume":"5","author":"E Baumrin","year":"2021","unstructured":"Baumrin E, Izaguirre NE, Bausk B, Feeley MM, Bay CP, Yang Q, et al. Safety and reactogenicity of the recombinant zoster vaccine after allogeneic hematopoietic cell transplantation. Blood Adv. 2021;5(6):1585\u201393. https:\/\/doi.org\/10.1182\/bloodadvances.2020003749.","journal-title":"Blood Adv"},{"issue":"2","key":"2670_CR31","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.bbmt.2013.11.013","volume":"20","author":"NC Issa","year":"2014","unstructured":"Issa NC, Marty FM, Leblebjian H, Galar A, Shea MM, Antin JH, et al. Live attenuated varicella-zoster vaccine in hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transpl. 2014;20(2):285\u20137. https:\/\/doi.org\/10.1016\/j.bbmt.2013.11.013.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"1","key":"2670_CR32","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/ajh.22196","volume":"87","author":"E Naidus","year":"2012","unstructured":"Naidus E, Damon L, Schwartz BS, Breed C, Liu C. Experience with use of zostavax ((r)) in patients with hematologic malignancy and hematopoietic cell transplant recipients. Am J Hematol. 2012;87(1):123\u20135. https:\/\/doi.org\/10.1002\/ajh.22196.","journal-title":"Am J Hematol"},{"issue":"11","key":"2670_CR33","doi-asserted-by":"publisher","first-page":"4144","DOI":"10.1080\/21645515.2021.1953346","volume":"17","author":"EA Stadtmauer","year":"2021","unstructured":"Stadtmauer EA, Sullivan KM, El IM, Salaun B, Alonso AA, Andreadis C, et al. Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice. Hum Vaccin Immunother. 2021;17(11):4144\u201354. https:\/\/doi.org\/10.1080\/21645515.2021.1953346.","journal-title":"Hum Vaccin Immunother"},{"issue":"12","key":"2670_CR34","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1016\/j.bbmt.2019.07.036","volume":"25","author":"D Curran","year":"2019","unstructured":"Curran D, Matthews S, Rowley SD, Young JH, Bastidas A, Anagnostopoulos A, et al. Recombinant zoster vaccine significantly reduces the impact on quality of life caused by herpes zoster in adult autologous hematopoietic stem cell transplant recipients: a randomized placebo-controlled trial (zoe-hsct). Biol Blood Marrow Transpl. 2019;25(12):2474\u201381. https:\/\/doi.org\/10.1016\/j.bbmt.2019.07.036.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"4","key":"2670_CR35","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1097\/j.pain.0000000000002760","volume":"164","author":"JH Kim","year":"2023","unstructured":"Kim JH, Johnson R, Kovac M, Cunningham AL, Amakrane M, Sullivan KM, et al. Adjuvanted recombinant zoster vaccine decreases herpes zoster-associated pain and the use of pain medication across 3 randomized, placebo-controlled trials. Pain. 2023;164(4):741\u20138. https:\/\/doi.org\/10.1097\/j.pain.0000000000002760.","journal-title":"Pain"},{"issue":"9","key":"2670_CR36","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/s1473-3099","volume":"2","author":"F Cainelli","year":"2002","unstructured":"Cainelli F, Vento S. Infections and solid organ transplant rejection: a cause-and-effect relationship? Lancet Infect Dis. 2002;2(9):539\u201349. https:\/\/doi.org\/10.1016\/s1473-3099.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"2670_CR37","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1111\/bjd.13894","volume":"173","author":"I Palacios-Alvarez","year":"2015","unstructured":"Palacios-Alvarez I, Santos-Briz A, Jorge-Finnigan C, Canueto J, Fernandez-Lopez E, Roman-Curto C. Chronic cutaneous lichenoid graft-versus-host disease at the area of herpes zoster infection and at a vaccination site. Br J Dermatol. 2015;173(4):1050\u20133. https:\/\/doi.org\/10.1111\/bjd.13894.","journal-title":"Br J Dermatol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02670-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02670-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02670-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T05:00:18Z","timestamp":1740978018000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02670-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,2]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2670"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02670-5","relation":{},"ISSN":["1743-422X"],"issn-type":[{"type":"electronic","value":"1743-422X"}],"subject":[],"published":{"date-parts":[[2025,3,2]]},"assertion":[{"value":"9 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This meta-analysis is based on previously published studies, and no new data were collected from human participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This meta-analysis included data from previously published studies. All original studies were conducted in accordance with ethical standards, and informed consent was obtained as required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}